Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reiterated by equities researchers at JPMorgan Chase & Co. in a research report issued on Monday.
Several other research firms have also recently commented on ROG. Citigroup Inc. reissued a “buy” rating on shares of Roche Holding in a research note on Friday, July 1st. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Roche Holding in a research note on Tuesday, July 19th.
Shares of Roche Holding (VTX:ROG) opened at 238.90 on Monday. The firm’s 50 day moving average price is CHK 241.54 and its 200-day moving average price is CHK 246.11. Roche Holding has a 1-year low of CHK 229.90 and a 1-year high of CHK 281.40. The company has a market capitalization of CHK 203.58 billion and a P/E ratio of 22.24.
About Roche Holding
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.